Page 3 - Off Label Indication News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Germany, drug shortages and supply problems have reached critical levels and are affecting the provision of care.

A new oral phosphodiesterase-4 (PDE4) inhibitor achieved impressive rates of complete or near-complete skin clearance in a phase 2 study that also found the drug was well tolerated.

Efforts to create a registry to track ketamine treatment has long been stymied. Amid an increase in off-label use, unregulated clinics, and relaxed DEA rules, has the field finally reached a tipping point?

Already approved for Dravet syndrome, fenfluramine's approval for seizure control in Lennox-Gastaut syndrome was supported by data from a global, phase 3 clinical trial.

It was just as prevalent but with better outcomes as transcatheter mitral-valve repair emerged to take on high-risk cases. But more than just a shift in case mix seems responsible, researchers say.